Vaccines for Actinobacillus pleuropneumoniae
US5417971A · kind A · utility
8Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1992 |
| Grant date | May 23, 1995 |
| Priority date | — |
| Expiry date | Oct 15, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one A. pleuropneumoniae transferrin binding protein and/or one A. pleuropneumoniae cytolysin and/or one A. pleuropneumoniae APP4. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.